http://sg.finance.yahoo.com/news/Vista-Partners-Updates-prnews-2118379740.html?x=0
SAN FRANCISCO, Nov. 16, 2011 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Cellmid Ltd. (ASX:CDY.ax - News) (the "Company") and raised its twelve month target price to AUD $0.12. Ross Silver, Principal Analyst at Vista Partners stated, "Cellmid is on track to enter clinical trials for its AMI indication with a market estimated to be in the billions. The Company recently completed humanisation of its "first in class" anti-midkine antibody, hu91, in collaboration with Antitope Ltd. The humanisation has been completed on time and within budget and resulted in a drug that can enter clinical development. This is the most significant milestone to date in the Company's antibody program and has removed a substantial risk from the clinical development path." Mr. Silver continued, "Cellmid has a large portfolio of patents surrounding midkine and owns 21 patent families worldwide. Cellmid plans to monetize this portfolio through two segments: Diagnostics and Therapeutics. The Diagnostic programs are in a more advanced stage and are poised to face regulatory approvals first. The Therapeutic programs are in pre-clinical trials; however they involve high value antibody candidates with early partner/licensing potential."
To download a FREE copy of the Cellmid Ltd. research report, please visit www.vistapglobal.com and complete the research form to gain access to the report.
About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of profitable investment ideas.
Disclaimer & Disclosure:
For a full list of disclaimers and disclosures, please visit our website www.vistapglobal.com or click here.
Contact:
877.215.4813 or [email protected]
vista partners updates coverage to $0.12
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $1.851K | 246.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2173225 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 150000 | 1 |
View Market Depth
| Last trade - 15.33pm 26/06/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |